Pharma Focus Europe


To provide readers with rich information and knowledge, this section of the website includes white papers that address current issues, technology, research, etc, covering every aspect of the pharmaceutical industry.

Spray Drying Biologics: An Alternative to Freeze Drying

Drug products containing active biological ingredients form one of the most important and fastestgrowing sectors of the pharmaceutical industry These biologics include a wide range of large complex molecules including protein

The New Normal: How COVID-19 Became the Catalyst for Change

When COVID disrupted life sciences solutions were needed in realtime As the pandemic grew so did the need to innovate Workers met the challenges They completed tasks fulfilled inspections and remained vigilant in fulfilling regulatory requirements This paper presents findings from a roundtable hosted by PharmaLex

Driving value creation through medical affairs in China

After more than three decades of fast economic growth China has entered the new normal stage marked by a moderate and stable domestic GDP growth rate Healthcare has been elevated to a national level agenda by the current leadership with the releasing of China Health

Launching Global Clinical Trials—best Practices For Efficient And Cost-effective Translations: A Lionsbridge White Paper

SummaryThe target market for conducting global clinical trials has changed significantly moving beyond pharmaceutical early adopters to the mainstream marketplace This shift has placed a heightened focus on the language challenges and complexity of running a global clinical trialMore and more companies are moving toward

Pharmacopeia Requirements For Pure Steam And Final Rinse Verification Of Cip: A METTLER TOLEDO White Paper

SummaryValidation of Pure Steam and the verification of the final aqueous rinse in a CIP process are defined by regulatory standards which change periodically and challenge system designers and owners to know the latest requirements This white paper contains an overview of current pharmacopeia requirements which will assist in the design and monitoring of comp

Effective Randomization Is Key To The Success Of A Trial: A Cenduit White Paper

SummaryRandomized doubleblind clinical trials are the gold standard for adequate and wellcontrolled studies in modern times However prior to the late s randomization and blinding were not used in medicine and as result bias was common For example treatment bias was often observed as physicians would treat sicker patients with known controls while

Improving Strategic Supplier Discovery Through Technology: A Procurepharma White Paper

SummaryThis white paper will explore current trends related to procurement and sourcing is evolving role in the supplier discovery process and current practices for accessing supplier information It will explore the ability of new technology to enable procurement and sourcing professionals to reduce the time spent identifying qualified suppliers prior to initiating the RFP process Finally

Meeting Current and Future Serialisation Challenges: An AESICA White Paper

SummarySerialisation has emerged as a complex challenge for the pharmaceuticals sector which is facing a multiplicity of differing regulations that vary from one country to another Several countries including China South Korea Turkey Argentina and Brazil already have regulations in place that must be complied with whilst many others including countries i

The Real Cost of Poor Data Integrity in Pharmaceutical Manufacturing: A Lachman White Paper

SummaryEvery business faces risk Broadly speaking the primary categories of business risk are Market Financial Execution and Regulatory Successful companies have developed a core competency in managing for these risks turning risk management into a sustainable competitive advantage For drug manufacturers recent trends have underscored the importance o

Indication-Specific Pricing Of Pharmaceuticals In The United States Health Care System: An ICER White Paper

SummaryThe Institute for Clinical and Economic Review ICER held a Policy Summit on December with health care leaders from the payer and life sciences organizations that comprise the ICER membership group The purpose of the meeting was to explore the potential value of indicationspecific pricing ISP of pharmaceuticals for both pay

Thermo Fisher Scientific - mRNA ServicesWorld Orphan Drug Congress 2024World Vaccine Congress Europe 2024Advanced Therapies USA 2024